C3.ai (AI.US) CEO's stock price plummeted due to health issues, Wedbush said the possibility of being acquired increased

Zhitongcaijing · 07/25 07:17

The Zhitong Finance App learned that the possibility of C3.ai (AI.US) being acquired has increased significantly. Earlier, the company announced that due to CEO Tom Siebel's health problems, the company has begun searching for a replacement. Wedbush analyst Dan Ives wrote in a report on Thursday: “We believe that the possibility that C3.ai will be acquired over the next 3 to 12 months has increased significantly following the news that Siebel will step down as CEO.” He gave C3.ai stock a rating of “outperforming the market” and set a price target of $35.

Ives sees C3.ai as “one of the most attractive M&A targets because the company focuses on the convergence of artificial intelligence, big data, and cloud computing.”

C3.ai Chairman and CEO Siebel said in a statement: “My eyesight was severely damaged after being diagnosed with an autoimmune disease in early 2025. To enable C3.ai to reach its full potential — which I think is amazing — the board and I have begun searching for a new CEO to take the company to the next phase of growth and success.”

C3.ai's stock price fell 9.5% after news broke about the CEO's upcoming departure, and finally closed down 10.84% on Thursday.